BioLife Solutions, Inc. - Common Stock (BLFS)
Frequently Asked Questions About BioLife Solutions, Inc. - Common Stock (BLFS)
Has BioLife Solutions, Inc. made any recent acquisitions?
Yes, BioLife Solutions has made strategic acquisitions in recent years to enhance its product offerings and expand its market reach. These acquisitions have solidified its position as a key player in the biopreservation market.
How does BioLife Solutions, Inc. ensure product quality?
BioLife Solutions adheres to strict quality control standards and regulatory compliance measures in all aspects of product development and manufacturing. This commitment ensures that their products consistently meet or exceed industry standards for quality and safety.
How does BioLife Solutions, Inc. support cell and gene therapies?
BioLife Solutions provides essential products and services that enhance the efficacy of cell and gene therapies, including biopreservation media that safeguard cells and tissues during storage and transport, ultimately aiding in successful medical outcomes for patients.
How many employees does BioLife Solutions, Inc. have?
BioLife Solutions, Inc. employs a growing number of professionals within the biotechnology sector, reflecting the company's expansion and its commitment to innovation. The precise employee count can vary, but the company aims to attract top talent to drive its initiatives.
Is BioLife Solutions, Inc. publicly traded?
Yes, BioLife Solutions, Inc. is publicly traded on the Nasdaq under the ticker symbol BLFS. Going public has allowed the company to raise capital and provide liquidity for its investors.
What are some challenges faced by BioLife Solutions, Inc.?
Like many companies in the biotech sector, BioLife Solutions faces challenges such as regulatory hurdles, market competition, and the need to continuously innovate to meet the fast-evolving demands of the industry.
What are the key markets for BioLife Solutions, Inc.?
BioLife Solutions operates in the global biopreservation market, which is a crucial segment of the biopharmaceutical industry. The company addresses the growing demand in cell and gene therapies, regenerative medicine, and other biotechnological applications.
What are the main products offered by BioLife Solutions, Inc.?
BioLife Solutions offers a range of products, including proprietary biopreservation media, cryopreservation containers, and a suite of thawing and storage equipment. Their innovative products are designed to maintain cell viability and integrity during the storage and transportation processes.
What are the regulatory requirements for BioLife Solutions, Inc.'s products?
BioLife Solutions, Inc. must adhere to stringent regulatory requirements set by agencies such as the FDA in the United States and similar organizations globally. These regulations ensure the safety, efficacy, and quality of their products aimed at therapeutic applications.
What distinguishes BioLife Solutions, Inc.'s products from competitors?
BioLife Solutions distinguishes itself through its proprietary biopreservation technologies, commitment to quality, and customer-centric approach. The company's products are rigorously tested to ensure superior performance in preserving cell functionality and viability.
What does BioLife Solutions, Inc. do?
BioLife Solutions, Inc. is a leading provider of bioproduction tools and services for cell and gene therapies. The company specializes in the development and commercialization of biopreservation media and cryopreservation equipment designed to enhance the viability and functionality of cells during storage and transport.
What is the future outlook for BioLife Solutions, Inc.?
The future outlook for BioLife Solutions appears promising, with increasing investments in cell and gene therapies and a growing global demand for effective biopreservation solutions. The company aims to expand its market presence and deliver innovative products to support the biopharmaceutical industry.
What is the significance of biopreservation for BioLife Solutions, Inc.?
Biopreservation is critical for maintaining the viability of cells and biological materials, which is essential for therapeutic applications. BioLife Solutions is focused on innovating and refining biopreservation techniques to ensure that cells remain functional and effective for therapeutic use.
What recent milestones has BioLife Solutions, Inc. achieved?
Recent milestones include expanding their product portfolio through key acquisitions, increasing global market penetration, and achieving significant partnerships with major biotech firms. These milestones demonstrate BioLife's commitment to growth and innovation in the biopreservation space.
What types of funding has BioLife Solutions, Inc. secured?
BioLife Solutions has secured various types of funding including equity financing from public markets due to its status as a publicly traded company, along with private investments and strategic partnerships, which support its growth initiatives and product development.
When was BioLife Solutions, Inc. founded?
BioLife Solutions, Inc. was founded in 1987. Over the years, it evolved from a company specializing in biopreservation products to a significant player in the cell and gene therapy markets, addressing growing demands in the biotech field.
Where is BioLife Solutions, Inc. headquartered?
BioLife Solutions, Inc. is headquartered in Bothell, Washington. The strategic location allows the company to tap into the vibrant biotech ecosystem of the Pacific Northwest.
Who are the primary customers of BioLife Solutions, Inc.?
BioLife Solutions primarily serves the biopharmaceutical and biotechnology sectors, including organizations involved in cell and gene therapy, regenerative medicine, and tissue engineering. Their customers range from large pharmaceutical companies to small biotech startups.
Who is the leadership team at BioLife Solutions, Inc.?
The leadership team at BioLife Solutions comprises experienced professionals with backgrounds in biotechnology, finance, and operations. Their combined expertise drives the company's strategic initiatives and operational excellence.
What is the current price of BioLife Solutions, Inc. - Common Stock?
The current price of BioLife Solutions, Inc. - Common Stock is 21.50
When was BioLife Solutions, Inc. - Common Stock last traded?
The last trade of BioLife Solutions, Inc. - Common Stock was at 4:00 pm EDT on April 17th, 2026
What is the market capitalization of BioLife Solutions, Inc. - Common Stock?
The market capitalization of BioLife Solutions, Inc. - Common Stock is 1.04B
How many shares of BioLife Solutions, Inc. - Common Stock are outstanding?
BioLife Solutions, Inc. - Common Stock has 48.30M shares outstanding.